ETC
LEGN icon

Exchange Traded Concepts’s Legend Biotech LEGN Stock Holding History

Exchange Traded Concepts’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,358
Closed -$114K – 1468
2025
Q1 		$114K Buy
3,358
+93
+3% +$3.33K ﹤0.01% 1113
2024
Q4 		$106K Hold
3,265
– – ﹤0.01% 1134
2024
Q3 		$159K Sell
3,265
-23
-0.7% -$1.23K ﹤0.01% 1045
2024
Q2 		$146K Sell
3,288
-1,022
-24% -$47.1K ﹤0.01% 909
2024
Q1 		$242K Buy
4,310
+2,197
+104% +$132K 0.01% 870
2023
Q4 		$127K Sell
2,113
-1,305
-38% -$82.7K ﹤0.01% 855
2023
Q3 		$230K Sell
3,418
-451
-12% -$31.3K 0.01% 782
2023
Q2 		$267K Buy
+3,869
New +$253K 0.01% 760

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Exchange Traded Concepts's LEGN Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 3,358 shares — an estimated $114K sold.

Exchange Traded Concepts first reported a position in LEGN in Q2 2023 and held it in 8 quarters. The position peaked at $267K in Q2 2023. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 3,358 Legend Biotech shares in Q2 2025, an estimated $114K.
  • Exchange Traded Concepts first reported a position in Legend Biotech in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Legend Biotech position peaked at $267K in Q2 2023.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.